Australia Streamlines Medical Product Advisory Committees

February 3, 2017

Australia’s Therapeutic Goods Administration streamlined its advisory committees for medical products following a review of the country’s regulatory framework for medical devices and drugs.

The authority has reduced the number of advisory committees — which provide independent advice used in making regulatory decisions — from 11 to seven.

Those committees are:

  • The Advisory Committee on Medical Devices;
  • The Advisory Committee on Medicines;
  • The Advisory Committee on Vaccines;
  • The Advisory Committee on Biologicals;
  • The Advisory Committee on Complementary Medicines; and
  • The Advisory Committees on Medicines Scheduling and Chemicals Scheduling. — Jeff Kinney

View today's stories